Showing results (171-180 of 334) with videos related to
Sort By:
Pageof 34
Plos One|April 22, 2016
mRNA-Mediated Gene Supplementation of Toll-Like Receptors as Treatment Strategy for Asthma In VivoFranziska Zeyer, Benedikt Mothes, Clara Will, et al.Stem Cells International|July 26, 2017
Safety and Tolerance of Donor-Derived Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation: The MYSTEP1 StudySteffen Hartleif, Michael Schumm, Michaela Döring, et al.The Hematology Journal : the Official Journal of the European Haematology Association|August 7, 2004
Impaired T-cell activation and cytokine productivity after transplantation of positively selected CD34+ allogeneic hematopoietic stem cellsMatthias Eyrich, Christine Leiler, Tanja Croner, et al.Immunology Letters|August 5, 2018
Human T cells modulate myeloid-derived suppressor cells through a TNF-α-mediated mechanismMarkus Bauswein, Anurag Singh, Anjali Ralhan, et al.Plos One|May 16, 2018
Correction: mRNA-Mediated Gene Supplementation of Toll-Like Receptors as Treatment Strategy for Asthma In VivoFranziska Zeyer, Benedikt Mothes, Clara Will, et al.Journal of Cancer Research and Clinical Oncology|February 15, 2020
Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantationKarin Melanie Cabanillas Stanchi, Julia Vek, Patrick Schlegel, et al.Blood|February 26, 2005
Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro inductionKarin Schilbach, Gunter Kerst, Steffen Walter, et al.Pain|February 23, 2010
Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodyniaLinda S Sorkin, Mario Otto, William M Baldwin, et al.Blood|October 24, 2002
Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemiaPeter Lang, Rupert Handgretinger, Dietrich Niethammer, et al.Journal of Cancer Research and Clinical Oncology|August 26, 2019
Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patientsKarin Melanie Cabanillas Stanchi, Manon Queudeville, Carmen Malaval, et al.Pageof 34